These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8231461)

  • 21. Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro.
    Swanson BN; Hichens M; Mojaverian P; Ferguson RK; Vlasses PH; Dudash M
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):525-36. PubMed ID: 6276950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is it possible to predict a decrease in portal pressure after administration of ACE inhibitors?].
    Svoboda P; Kantorová I; Ochmann J
    Vnitr Lek; 1994 Mar; 40(3):170-3. PubMed ID: 8184570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach.
    Ribeiro W; Muscará MN; Martins AR; Moreno H; Mendes GB; de Nucci G
    Eur J Clin Pharmacol; 1996; 50(5):399-405. PubMed ID: 8839663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurements.
    Brockmeier D
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):631-8. PubMed ID: 8963479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic determination of enalapril in human plasma by enzyme kinetic analytical method.
    Thongnopnua P; Poeaknapo C
    J Pharm Biomed Anal; 2005 Apr; 37(4):763-9. PubMed ID: 15797799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.
    Johnston CI; Jackson B; Cubela R; Larmour I; Arnolda L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S9-14. PubMed ID: 2422495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
    Shalaby SM; Zakora M; Otte J
    J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review).
    Cziráki A; Horváth IG; Papp L
    Int J Mol Med; 2002 Mar; 9(3):317-25. PubMed ID: 11836639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of bilirubin on the spectrophotometric and radionuclide assay for serum angiotensin-converting enzyme.
    Saxe AW; Hollinger MA; Essam T
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):129-36. PubMed ID: 3006193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K; Inoue Y; Kokubu T
    Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction.
    Guazzi MD; Campodonico J; Celeste F; Guazzi M; Santambrogio G; Rossi M; Trabattoni D; Alimento M
    Clin Pharmacol Ther; 1998 Jan; 63(1):79-86. PubMed ID: 9465844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.
    Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V
    Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays.
    Arafat T; Awad R; Hamad M; Azzam R; Al-Nasan A; Jehanli A; Matalka K
    J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
    Li GH; Qu MR; Wan JZ; You JM
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of angiotensin converting enzyme inhibitors on 1.25-(OH)2 D levels of hypertensive patients. Relationship with ACE polymorphisms.
    Pérez-Castrillón JL; Justo I; Sanz A; De Luis D; Dueñas A
    Horm Metab Res; 2006 Dec; 38(12):812-6. PubMed ID: 17163356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent inhibition of angiotensin converting enzyme by enalapril in cats.
    Uechi M; Imamoto S; Ishikawa Y
    J Vet Med Sci; 2002 Apr; 64(4):385-7. PubMed ID: 12014588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.